Wealth Management Associates’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
IA
VCM
VAM
Wealth Management Associates's AZN Position: Q1 2026 in Review
Wealth Management Associates increased its AstraZeneca (AZN) stake by 8.7% in Q1 2026, buying an estimated $27.4K and bringing the position to 1,780 shares worth $351K. The position accounts for 0.12% of the portfolio, ranked #151.
Wealth Management Associates first reported a position in AZN in Q4 2022 and has held it in 6 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Wealth Management Associates held 1,780 shares of AstraZeneca worth $351K as of Q1 2026.
- Wealth Management Associates bought 142 AstraZeneca shares in Q1 2026, an estimated $27.4K.
- AstraZeneca made up 0.12% of Wealth Management Associates's portfolio in Q1 2026, its #151 holding.
- Wealth Management Associates first reported a position in AstraZeneca in Q4 2022 and has held it in 6 quarters since.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Wealth Management Associates's 13F filing for Q1 2026, filed 13 May 2026.